Sterling announces pilot plant facility expansion is operational

NEWCASTLE, UK - Jun 4, 2019 - Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million investment last year

BioIVT HEPATOPAC® Meeting to Highlight Advances in Drug Discovery Research

WESTBURY, NY - Jun 3, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a HEPATOPAC Meeting at the AC Hotel by Marriott, San Francisco Airport/Oyster Point Waterfront on June 7

BOC Sciences to Reorganize Custom Synthesis for the Pharmaceutical Industry

SHIRLEY, LONG ISLAND CITY, NY, UNITED STATES - Jun 3, 2019 - The New York-based chemical vendor BOC Sciences announces to reorganize its custom synthesis for the pharmaceutical industry

MR Solutions’ multi-modality, cryogen free technology is recognised as the norm at the ISMRM meeting in Montreal

GUILDFORD, UNITED KINGDOM - May 24, 2019 - MR Solutions’ high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM)[i], in Montreal last week

CRF Bracket’s World-Class Clinical Research Technology wins European PIN Award for Second Year in Row

PHILADELPHIA, PA - May 30, 2019 - CRF Bracket’s Romania office celebrates yet another European award after being named IT Company of the Year in Romania’s Regional IT & Outsourcing Industry Awards (also known as the PIN Awards)

Creative Biolabs Released Professional Carbohydrate Based Conjugation Services

SHIRLEY, NY, UNITED STATES - May 30, 2019 - Creative Biolabs, a global company pioneering new biotechnologies, released professional carbohydrate based conjugation services in order to regulate antigen interaction

Microway Boosts Solutions with 2nd Generation Intel Xeon Scalable Processors

PLYMOUTH, MA, US - May 29, 2019 -  Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces that bleeding-edge 2nd Generation Intel®  Xeon® Scalable processors (“Cascade Lake-SP”) are now shipping in volume across all Microway Xeon offerings, including next-generation NumberSmasher™ clusters, servers, and WhisperStations

BioIVT Named Service Provider for Promega Immunotherapy Bioassays

WESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research

BOC Sciences Continues to Broaden Its Inhibitor Range for Researchers

SHIRLEY, NY, UNITED STATES - May 29, 2019 - As one of the world's leading chemical suppliers, BOC Sciences announces to continuously broaden its small molecule inhibitor range in response to an increasingly urgent need to find a cure for some major diseases that are inflicting the human beings

Creative Proteomics Has Announced a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services

SHIRLEY, NY - May 29, 2019 - SHIRLEY, NY – May 29, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchers

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference

PITTSBURGH, PA, UNITED STATES - May 24, 2019 - Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida

Certara Introduces Integral, its Next-generation Data Repository

PRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral™, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical data

Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data

MILFORD, MA, US - May 25, 2019 -

• TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system 
• Significant increase in diuresis, net negative fluid balance, improvement of kidney function and improvement in clinical symptoms
• Significant drop in CVP while systolic BP remained stable

Creative Diagnostics Launches IHC/Pathology Antibodies for Research

SHIRLEY, NY, UNITED STATES - May 28, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced it has launched a series of IHC/Pathology antibodies for research use

CanDIG to be part of new Canadian Digital Health and Discovery Platform

MONTRÉAL, QC, CANADA - May 27, 2019 - Today, Minister Navdeep Bains announced funding for the Digital Health and Discovery Platform (DHDP) through the health and biosciences stream of the Strategic Innovation Fund

Creative Proteomics Upgrades a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services

SHIRLEY, NY - May 25, 2019 - SHIRLEY, NY – May 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchers

Cala Health Raises $50 Million Series C Funding

BURLINGAME, CA, UNITED STATES - May 21, 2019 - Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced it has completed a $50 million Series C financing

PROMINENT TECHNOLOGIST WILLIAM F. (BILL) STASIOR JOINS AVELLINO LABS EXECUTIVE ADVISORY COMMITTEE

MENLO PARK, CA - May 23, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today the addition of William F

TTS Pharma Limited announces closing of £10.3 million fundraising and new board appointment

LONDON AND LIVERPOOL, UK - May 23, 2019 -

• The completion of series B fundraise of £10.3 million
• The appointment of Paul Atherton as Chairman

CD Genomics Announces Highly Accurate and Sensitive Genome Sequencing Services for Conducting a Genome-wide Analysis

SHIRLEY, NY, UNITED STATES - May 22, 2019 - SHIRLEY, NY, UNITED STATES – May 23, 2019 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the technical escalation of its sequencing services, The updated or newly-developed service ranges include three: nanopore sequencing, mitochondrial genome sequencing, and whole plasmid sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity